Hillary Clinton won't dampen pharma sector: Analyst By: CNBC.com News September 23, 2015 at 15:09 PM EDT Despite a drop in biotech stocks this week after talk about price gouging, an analyst said Wednesday that the sector remains a good investment. Read More >> Related Stocks: Nasdaq Biotechnology Ishares ETF Pacira Pharm Inc